NCT07395336
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07395336
Title Elacestrant and Exemestane for Patients With Pretreated HR+/HER2- Metastatic Breast Cancer and [18F] FES-avid Lesions (COMBINE) (COMBINE-01)
Acronym COMBINE-01
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Institute of Oncology
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.